COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,633 Articles (22,913 medRxiv, 8,720 bioRxiv)

Most recent first Previous |  Page 1854: Articles 18531-18540  | Next

Disruption of nuclear architecture as a cause of COVID-19 induced anosmia
Zazhytska, M., Kodra, A., Hoagland, D. A., Fullard, J., Shayya, H. J., Omer, A., Firestein, S., Gong, Q., Canoll, P., Goldman, J. E., Roussos, P., tenOever, B. R., Overdevest, J. B., Lomvardas, S.
10.1101/2021.02.09.430314 — Posted: 2021-02-09
Exosomes from COVID-19 patients carry tenascin-C and fibrinogen-β in triggering inflammatory signals in distant organ cells
Sur, S., Khatun, M. B., Steele, R., Isbell, S., Ray, R., Ray, R. B.
10.1101/2021.02.08.430369 — Posted: 2021-02-09
Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression
Maulding, N. D., Seiler, S., Pearson, A., Kreusser, N., Stuart, J.
10.1101/2021.02.09.430517 — Posted: 2021-02-09
A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: effects on proteolytic cleavage and ACE2 binding
Spelios, M. G., Capanelli, J. M., Li, A. W.
10.1101/2021.02.09.430451 — Posted: 2021-02-09
SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies
Valdes-Balbin, Y., Santana-Mederos, D., Quintero, L., Fernandez, S., Rodriguez, L., Sanchez-Ramirez, B., Perez, R., Acosta, C., Mendez, Y., Ricardo, M. G., Hernandez, T., Bergado, G., Pi, F., Valdes, A., Ramirez, U., Oliva, R., Soubal, J.-P., Garrido, R., Cardoso, F., Landys, M., Farinas, M., Gonzalez, H., Enriquez, J., Noa, E., Suarez, A., Fang, C., Espinosa, L. A., Ramos, Y., Gonzalez, L. J., Climent, Y., Rojas, G., Relova-Hernandez, E., Cabrera, Y., Losada, S. L., Boggiano, T., Ojito, E., Leon-Monzon, K., Chiodo, F., Paquet, F., Chen, G., Rivera, D. G., Garcia-Rivera, D., Verez-Bencomo, V.
10.1101/2021.02.08.430146 — Posted: 2021-02-09
GABA administration limits viral replication and pneumonitis in a mouse model of COVID-19
Tian, J., Middleton, B., Kaufman, D. L.
10.1101/2021.02.09.430446 — Posted: 2021-02-09 Discussion: Onsite
Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids
Zhao, H., Wu, D., Nguyen, A., Li, Y., Adão, R., Valkov, E., Patterson, G. H., Piszczek, G., Schuck, P.
10.1101/2021.02.08.430344 — Posted: 2021-02-09
Transformations, Comparisons, and Analysis of Down to Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein Including the UK Variant B.1.1.7
peters, m. h., Basidas, O., Kokron, D., Henze, C. E.
10.1101/2021.02.09.430519 — Posted: 2021-02-09
High Throughput Nanopore Sequencing of SARS-CoV-2 Viral Genomes from Patient Samples
Pater, A. A., Bosmeny, M. S., Parasrampuria, M., Eddington, S. B., Ovington, K. N., Barkau, C. L., White, A. A., Metz, P. E., Sylvain, R. J., Chilamkurthy, R., Yinusa, A. O., Benzinger, S. W., Hebert, M. M., Gagnon, K. T.
10.1101/2021.02.09.430478 — Posted: 2021-02-09
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
Wu, X., Cheng, L., Fu, M., Huang, B., Zhu, L., Xu, S., Shi, H., Zhang, D., Yuan, H., Nawaz, W., Yang, P., Hu, Q., Liu, Y., Wu, Z.
10.1101/2021.02.08.429275 — Posted: 2021-02-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).